CliffBio
small molecule

SEEBRI NEOHALER

GLYCOPYRROLATE

Loss of exclusivityOctober 2028latest FDA-listed patent expiry
CompanyNovartis →See this company's full patent-cliff portfolio

Drug detail

Brand nameSEEBRI NEOHALER
Active ingredientGLYCOPYRROLATE
Strength15.6MCG/INH
Dosage formPOWDER
RouteINHALATION
ModalitySmall molecule
FDA approvalOctober 2015
Marketing statusDISCN

Listed patents

PatentExpiresType
8182838October 2028product
8479730October 2028product

More from Novartis

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.